regeneron glp-1 Hansoh licensing deal provides with HS-20094, a GLP-1/GIP receptor agonist Regeneron gains rights to Hansoh's

Patient safety issues in the GLP-1 space this week The U.K.'s Manchester Evening News reported on marketers promoting retatrutide to millions of users on social media despite the fact that the drug has not been approved anywhere in the world and cannot be obtained safely outside of Eli Lillys phase three clinical trials

Misra SL, Patel DV, McGhee CNJ, et al

212214 GLP-1 RAs reverse detrimental epigenetic changes by promoting the demethylation of the GLP-1R gene, thereby restoring its expression and improving insulin sensitivity

Korner M, Stockli M, Waser B, Reubi JC

We're used to someone not eating or drinking after midnight the night before surgery and then assuming that their stomach would be empty

However, they can also affect digestion and how much you naturally feel like eating or drinking